RHUBARB AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR STUDY RACE II
大黄和血管紧张素转换酶抑制剂研究竞赛 II
基本信息
- 批准号:8167020
- 负责人:
- 金额:$ 0.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-03-01 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:AdultAngiotensin-Converting Enzyme InhibitorsAsiansChinaChinese HerbsComputer Retrieval of Information on Scientific Projects DatabaseConstipationCountryDiabetes MellitusDouble-Blind MethodFundingGrantInstitutionPatientsPlant PreparationsRaceRandomizedResearchResearch DesignResearch PersonnelResourcesRhubarb foodSourceTNF geneTransforming Growth Factor betaUnited States National Institutes of Healthplacebo controlled studypreventprospective
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Patients in China has suggested that rhubarb extract when used alone is equivalent to the protection afforded by ACEI. Furthermore when used in combination with ACEI, the renoprotective effect of rhubarb appears to be additive.
Rhubarb extract is a chinese herbal preparation that is used extensively in china and other asian countries to treat constipation and CKD. Its mechanism of action in preventing progression of CKD is uncertain but perhaps related to TGF beta and TNF alph inhibition.
The proposed study will be a prospective randomized double blinded placebo controlled study design to evaluate the efficacy of Rhubarb in addition to ACEI in proventing progression of CKD in adult patients with diabetes.
这个子项目是众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John M. Burkart其他文献
Prevalence of missed treatments and early sign-offs in hemodialysis patients.
血液透析患者错过治疗和过早退出的发生率。
- DOI:
- 发表时间:
1993 - 期刊:
- 影响因子:13.6
- 作者:
Michael V. Rocco;John M. Burkart - 通讯作者:
John M. Burkart
An international study of patient compliance with hemodialysis.
一项关于患者血液透析依从性的国际研究。
- DOI:
10.1001/jama.281.13.1211 - 发表时间:
1999 - 期刊:
- 影响因子:0
- 作者:
A. Bleyer;Britta Hylander;Hiroshi Sudo;Yasuo Nomoto;Ernesto de la Torre;Randolph A. Chen;John M. Burkart - 通讯作者:
John M. Burkart
Dialysis modality and delayed graft function after cadaveric renal transplantation.
尸体肾移植后的透析方式和移植物功能延迟。
- DOI:
- 发表时间:
1999 - 期刊:
- 影响因子:13.6
- 作者:
A. Bleyer;John M. Burkart;Gregory B. Russell;Patricia L. Adams - 通讯作者:
Patricia L. Adams
Utilization of inpatient and outpatient resources for the management of hemodialysis access complications.
利用住院和门诊资源来管理血液透析通路并发症。
- DOI:
- 发表时间:
1996 - 期刊:
- 影响因子:13.2
- 作者:
Michael V. Rocco;A. Bleyer;John M. Burkart - 通讯作者:
John M. Burkart
The effect of increasing hematocrit on peritoneal transport kinetics.
增加血细胞比容对腹膜转运动力学的影响。
- DOI:
- 发表时间:
1994 - 期刊:
- 影响因子:13.6
- 作者:
John M. Burkart;Barry I. Freedman;Michael V. Rocco - 通讯作者:
Michael V. Rocco
John M. Burkart的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John M. Burkart', 18)}}的其他基金
RHUBARB AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR STUDY (RACE) II
大黄和血管紧张素转换酶抑制剂研究(种族)II
- 批准号:
7951390 - 财政年份:2009
- 资助金额:
$ 0.29万 - 项目类别:
NUTRINEAL REPLACEMENT OF AMINO ACID LOSSES IN CONTINUOUS PERITONEAL DIALYSIS
连续腹膜透析中氨基酸损失的营养补充
- 批准号:
6253774 - 财政年份:1997
- 资助金额:
$ 0.29万 - 项目类别:
相似海外基金
Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia
中枢作用血管紧张素转换酶抑制剂减缓痴呆进展的效用
- 批准号:
10259832 - 财政年份:2020
- 资助金额:
$ 0.29万 - 项目类别:
Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia
中枢作用血管紧张素转换酶抑制剂减缓痴呆进展的效用
- 批准号:
10642850 - 财政年份:2020
- 资助金额:
$ 0.29万 - 项目类别:
Utility of Centrally Acting Angiotensin Converting Enzyme Inhibitors to slow the progression of Dementia
中枢作用血管紧张素转换酶抑制剂减缓痴呆进展的效用
- 批准号:
10408178 - 财政年份:2020
- 资助金额:
$ 0.29万 - 项目类别:
Evaluating the synergistic effects of HMG-CoA reductase inhibitors and angiotensin converting enzyme inhibitors in a rabbit model of aortic valve sclerosis using computed tomography and magnetic resonance imaging.
使用计算机断层扫描和磁共振成像评估 HMG-CoA 还原酶抑制剂和血管紧张素转换酶抑制剂在主动脉瓣硬化兔模型中的协同作用。
- 批准号:
183194 - 财政年份:2009
- 资助金额:
$ 0.29万 - 项目类别:
Studentship Programs
Potential role for angiotensin-converting enzyme inhibitors in the treatment of patients with normal-tension glaucoma
血管紧张素转换酶抑制剂在治疗正常眼压性青光眼患者中的潜在作用
- 批准号:
20592078 - 财政年份:2008
- 资助金额:
$ 0.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PREVENTION OF EVENTS WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS
使用血管紧张素转换酶抑制剂预防事件
- 批准号:
6304989 - 财政年份:1999
- 资助金额:
$ 0.29万 - 项目类别:
PREVENTION OF EVENTS WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS
使用血管紧张素转换酶抑制剂预防事件
- 批准号:
6114904 - 财政年份:1998
- 资助金额:
$ 0.29万 - 项目类别:
PREVENTION OF EVENTS WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS
使用血管紧张素转换酶抑制剂预防事件
- 批准号:
6218497 - 财政年份:1998
- 资助金额:
$ 0.29万 - 项目类别:
PREVENTION OF EVENTS WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS
使用血管紧张素转换酶抑制剂预防事件
- 批准号:
6276139 - 财政年份:1997
- 资助金额:
$ 0.29万 - 项目类别:
ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND PROSTACYCLIN SYNTHESIS
血管紧张素转换酶抑制剂和前列环素合成
- 批准号:
3762420 - 财政年份:
- 资助金额:
$ 0.29万 - 项目类别: